The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting ...

Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma ...

At AAPS PharmSci 360, Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer ...

Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for ...

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.

Redica Systems has been assisting pharmaceutical companies in determining GMP quality risks at their manufacturing sites, and ...

Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective ...

Regulators, EMA and HMA, have published principles and recommendations on the use of LLMs, which are being increasingly used ...

Anil Andrade, vice-president of Global Sales at ACG World, shared insights about the growth in demand in the pharma industry and efforts put forth to achieve sustainable operations. Pharmaceutical ...